Shares of Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report) traded up 21.4% during mid-day trading on Wednesday . The company traded as high as C$0.09 and last traded at C$0.09. 1,238,946 shares changed hands during trading, an increase of 1,152% from the average session volume of 98,928 shares. The stock had previously closed at C$0.07.
Voyageur Pharmaceuticals Stock Performance
The company has a market capitalization of C$14.64 million, a price-to-earnings ratio of -10.50 and a beta of 0.32. The firm has a fifty day simple moving average of C$0.07 and a 200 day simple moving average of C$0.06. The company has a debt-to-equity ratio of 3.21, a current ratio of 0.17 and a quick ratio of 0.84.
Voyageur Pharmaceuticals Company Profile
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.
See Also
- Five stocks we like better than Voyageur Pharmaceuticals
- Most active stocks: Dollar volume vs share volume
- Novo Nordisk: A New Boost for GLP-1 Sales on the Horizon
- How to Capture the Benefits of Dividend Increases
- Why Now Is the Ultimate Time to Invest in Oil Stocks
- 3 Fintech Stocks With Good 2021 Prospects
- Q4’s Most Upgraded Stocks: Promising Buys for 2025
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
